3 Health Services Stocks Moving The Industry Upward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 37 points (0.2%) at 16,943 as of Wednesday, July 9, 2014, 12:45 PM ET. The NYSE advances/declines ratio sits at 1,468 issues advancing vs. 1,471 declining with 161 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is up 0.3%. Top gainers within the industry include Opko Health ( OPK), up 2.3%, Cooper Companies ( COO), up 1.7%, Universal Health Services ( UHS), up 0.7%, Edwards Lifesciences ( EW), up 0.7% and Smith & Nephew ( SNN), up 0.6%. A company within the industry that fell today was Agilent Technologies ( A), up 0.7%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Baxter International ( BAX) is one of the companies pushing the Health Services industry higher today. As of noon trading, Baxter International is up $0.62 (0.8%) to $76.00 on average volume. Thus far, 1.2 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $75.14-$76.05 after having opened the day at $75.14 as compared to the previous trading day's close of $75.38.

Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $40.6 billion and is part of the health care sector. Shares are up 8.4% year-to-date as of the close of trading on Tuesday. Currently there are 4 analysts who rate Baxter International a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, increase in stock price during the past year and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, WellPoint ( WLP) is up $1.00 (0.9%) to $110.46 on average volume. Thus far, 785,541 shares of WellPoint exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $109.39-$110.68 after having opened the day at $109.41 as compared to the previous trading day's close of $109.46.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $30.5 billion and is part of the health care sector. Shares are up 18.5% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts who rate WellPoint a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, UnitedHealth Group ( UNH) is up $0.49 (0.6%) to $82.42 on light volume. Thus far, 943,993 shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.1 million shares. The stock has ranged in price between $81.89-$82.48 after having opened the day at $81.98 as compared to the previous trading day's close of $81.93.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $80.6 billion and is part of the health care sector. Shares are up 8.8% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts who rate UnitedHealth Group a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full UnitedHealth Group Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations

Jim Cramer Just Spoke to Larry Kudlow About the China Trade Negotiations

Stocks Rise, Facebook Ignites a Nasdaq Rally

Stocks Rise, Facebook Ignites a Nasdaq Rally

Short Seller Chanos Slams Tesla's Musk, Accuses Him of 'Incinerating' Capital

Short Seller Chanos Slams Tesla's Musk, Accuses Him of 'Incinerating' Capital

AMD Shares Explode After Solid Q1, Robust Outlook That Defies Chip Sector Gloom

AMD Shares Explode After Solid Q1, Robust Outlook That Defies Chip Sector Gloom

Facebook Stock Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts

Facebook Stock Set for Biggest Gain in Two Years After Q1 Earnings Top Forecasts